ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

HFS Research recognizes Indegene as a Market Leader in the HFS Horizons: Life Sciences Service Providers, 2023 report

PRINCETON, N.J., Nov. 20, 2023 (GLOBE NEWSWIRE) -- HFS, a leading global research and analysis firm, recognizes Indegene as a Market Leader in the HFS Horizons: Life Sciences Service Providers, 2023 report. HFS attributed the recognition to Indegene’s continued focus on innovation, strong client-centric and outcome-driven approach, and deep domain expertise, backed by a robust partner ecosystem.

"Indegene's meaningful impact on the triple aim of care (reducing cost of care, enhancing the experience of care, and improving health outcomes) with quantifiable evidence sets it apart in its ability to deliver value that positively addresses human lives”, said Rohan Kulkarni, Vice President and Global Practice Leader, Healthcare and Life Sciences Research, HFS.

Life Sciences Service Providers, 2023

“Increasingly, life sciences companies are turning to specialist service providers with deep domain knowledge and contemporary technology capabilities to help them accelerate their digital transformation”, said Gaurav Kapoor, EVP, Indegene. “HFS Research’s recognition validates our clients’ trust in our team to bring these capabilities together and enable them to improve health outcomes for all.”

The HFS Horizons: Life Sciences Service Providers, 2023 report examined the role and capabilities of 29 leading service providers across the global life sciences industry. The report specifically focuses on the domain-specific capabilities of these service providers across many dimensions, spanning value proposition, innovation capabilities, go-to-market strategy, and market impact.

To download the full report, click here.

About Indegene

Indegene is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives Indegene’s team and their purpose to enable healthcare organizations be future ready. To learn more, please visit www.indegene.com

About HFS Research

HFS is a leading global research and analysis firm trusted at the highest levels of executive leadership. Our mission is to help our clients tackle challenges, make bold moves, and bring big ideas to life by arming them with accurate, visionary, and thought-provoking insight into issues that impact their business.

HFS analysts and strategists have deep, real-world experience in the subjects they cover. They’re respected for their independent, no-nonsense perspectives based on thorough research, demand-side data, and personal engagements with industry leaders.

To learn more about HFS’ extensive suite of reports and services, please visit www.hfsresearch.com

For media inquiries, please contact:

Yadunandan K V | yadunandan.kv@indegene.com

Emma Melando | emma.melando@hfsresearch.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e63a5051-4d7a-4073-8a24-e979a65730b2


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.